Intuitive Q1 revenue $1.89B (+11% YoY), GAAP EPS $1.51, da Vinci procedures +16%

INTUITIVE SURGICAL INC

2024-Q1 EPS reported $1.51 revenue$1,890,600,000

Q1 revenue $1.89B (+11% YoY); GAAP EPS $1.51, non-GAAP EPS $1.50; procedure volume +16%.
Placed 313 da Vinci systems (8 da Vinci 5, 8 SP in Europe); installed base 8,887 (+14% YoY).
CE mark for da Vinci SP in Europe; FDA clearance for da Vinci 5; NMPA clearance for Ion in China.
Instruments & accessories revenue $1.16B (+18%); systems revenue $418M (slight decline).
Cash $7.32B; no COVID-19 procedure disruptions in Q1.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

INTUITIVE SURGICAL INC reported the quarter ended March 31, 2024 results: revenue $1.89 billion, net income $545 million, EPS $1.51 per diluted share.

Period: the quarter ended March 31, 2024
Revenue: $1.89 billion
Net income: $545 million
EPS: $1.51 per diluted share
Result: reported results

Exact text from the filing

First quarter 2024 revenue of $1.89 billion increased 11% compared with $1.70 billion in the first quarter of 2023.

View on SEC.gov

499 earnings releases filed in the last 30 days. Browse all earnings releases →

INTUITIVE SURGICAL INC filing history →

Source: SEC EDGAR

accession 0001035267-24-000133

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.